Evidence map›Paper›PMID 26770737›Full record

ReviewSAGE open medicine2014

Natural products as potential cancer therapy enhancers: A preclinical update.

Abed Agbarya, Nili Ruimi, Ron Epelbaum, Eran Ben-Arye, Jamal Mahajna

Open access · goldAbstract readReview
In one paragraph

Review in SAGE open medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antioxidants (Basel, Switzerland) · 2021
    Article
  12. Review
  13. Molecules (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Honey and its nutritional and anti-inflammatory value.BMC complementary medicine and therapies · 2021
    Review
  16. Article
  17. Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Abed AgbaryaThoracic Oncology Clinic, Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Nili RuimiCancer Drug Discovery Program, MIGAL-Galilee Research Institute, Kiryat Shmona, Israel.
Ron EpelbaumThoracic Oncology Clinic, Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Eran Ben-AryeComplementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Integrative Oncology Program, The Oncology Service, Lin Medical center, Clalit Health Services, Haifa and Western Galilee District, Israel.
Jamal MahajnaCancer Drug Discovery Program, MIGAL-Galilee Research Institute, Kiryat Shmona, Israel; Department of Nutritional Sciences, Tel-Hai College, Kiryat Shmona, Israel.
Migal - Galilee Technology Center · ILRambam Health Care Campus · ILClalit Health Services · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a multifactorial disease that arises as a consequence of alterations in many physiological processes. Recently, hallmarks of cancer were suggested that include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis, along with two emerging hallmarks including reprogramming energy metabolism and escaping immune destruction. Treating multifactorial diseases, such as cancer with agents targeting a single target, might provide partial treatment and, in many cases, disappointing cure rates. Epidemiological studies have consistently shown that the regular consumption of fruits and vegetables is strongly associated with a reduced risk of developing chronic diseases, such as cardiovascular diseases and cancer. Since ancient times, plants, herbs, and other natural products have been used as healing agents. Moreover, the majority of the medicinal substances available today have their origin in natural compounds. Traditionally, pharmaceuticals are used to cure diseases, and nutrition and herbs are used to prevent disease and to provide an optimal balance of macro- and micro-nutrients needed for good health. We explored the combination of natural products, dietary nutrition, and cancer chemotherapeutics for improving the efficacy of cancer chemotherapeutics and negating side effects.

Indexed as

Cancercancer therapyherbsnatural productsnutrition

Identifiers

PMID26770737
PMCPMC4607199
OpenAlexW2101163417

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.